Table 1.
Baseline characteristics of the subjects with and without non-alcoholic fatty liver disease
| Variable | NAFLD | Non-NAFLD | t value | P value |
| Age (yr) | 43.38 (0.42) | 40.14 (0.35) | 5.944 | < 0.001 |
| Gender, male/female (n) | 598/93 | 685/572 | 203.663 | < 0.001 |
| BMI (kg/m2) | 25.69 (0.09) | 21.83 (0.07) | 33.044 | < 0.001 |
| SBP (mmHg) | 128.62 (0.6) | 117.49 (0.43) | 15.253 | < 0.001 |
| DBP (mmHg) | 79.73 (0.36) | 72.71 (0.27) | 15.608 | < 0.001 |
| Hb (g/L) | 151.3 (0.46) | 141.62 (0.41) | 15.679 | < 0.001 |
| PLT (× 109/L) | 209.44 (2.12) | 206.1 (1.5) | 1.299 | 0.194 |
| WBC (× 109/L) | 6.48 (0.06) | 5.91 (0.04) | 8.294 | < 0.001 |
| SUA (μmol/L) | 367.92 (3.45) | 291.89 (2.32) | 18.742 | < 0.001 |
| FPG (mmol/L) | 5.01 (0.05) | 4.59 (0.02) | 8.019 | < 0.001 |
| TG (mmol/L) | 2.47 (0.07) | 1.3 (0.03) | 15.096 | < 0.001 |
| TC (mmol/L) | 4.94 (0.03) | 4.6 (0.02) | 8.128 | < 0.001 |
| LDL (mmol/L) | 2.35 (0.03) | 2.16 (0.03) | 4.487 | < 0.001 |
| VLDL (mmol/L) | 1.41 (0.03) | 1.01 (0.02) | 10.996 | < 0.001 |
| HLDL (mmol/L) | 1.16 (0.01) | 1.44 (0.01) | -20.396 | < 0.001 |
| ALT (U/L) | 36.24 (0.9) | 19.75 (0.41) | 16.649 | < 0.001 |
| AST (U/L) | 27.21 (0.43) | 22.1 (0.25) | 10.200 | < 0.001 |
| γ-GT (U/L) | 49.97 (1.51) | 25.56 (0.99) | 13.512 | < 0.001 |
NAFLD: Non-alcoholic fatty liver disease; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; Hb: Hemoglobin; PLT: Platelet; WBC: White blood cell; SUA: Serum uric acid; FPG: Fasting plasma glucose; TG: Triglycerides; TC: Total cholesterol; LDL: Low-density lipoprotein; VLDL: Very low-density lipoprotein; HDL: High-density lipoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; γ-GT: Gamma-glutamyl transpeptidase.